Effects of Diabetes on Murine Lipoproteins and Vascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|11|1196-1202

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.11, 2007-11, pp. : 1196-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Propionyl-Carnitine in Patients with Type 2 Diabetes and Peripheral Vascular Disease: Results of a Pilot Trial

By Ragozzino G.   Mattera E.   Madrid E.   Salomone P.   Fasano C.   Gioia F.   Acerra G.   Raffaele del Guercio   Federico P.  

Drugs in R&D, Vol. 5, Iss. 4, 2004-01 ,pp. : 185-190

Adis International

Access to resources Recommend Favorite

Editorial (Diabetes, Obesity and Vascular Disease - An Update)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 27, 2013-08 ,pp. : 4900-4903

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes

By Ramachandran Surya   Kartha C.C.  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 8, 2012-08 ,pp. : 1005-1015

NRC Research Press

Access to resources Recommend Favorite

Immunosuppression and transplant vascular disease: benefits and adverse effects

By Moien-Afshari F.   McManus B.M.   Laher I.  

Pharmacology and Therapeutics, Vol. 100, Iss. 2, 2003-11 ,pp. : 141-156

Elsevier

Access to resources Recommend Favorite

Atherosclerosis and Vascular Disease: Effects of Peptide Mimetics of Apolipoproteins

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 4, 2006-08 ,pp. : 235-240

Bentham Science Publishers

Access to resources Recommend Favorite